Trial Profile
A real life study evaluating baseline characteristics and treatment patterns of paliperidone palmitate in patients with schizophrenia
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Apr 2018
Price :
$35
*
At a glance
- Drugs Paliperidone (Primary)
- Indications Schizophrenia
- Focus Therapeutic Use
- 05 Apr 2018 New trial record